Native Bacterial and Viral Antigens Market to Grow at a CAGR of 6.8% to reach US$ 28,801.15 thousand from 2020 to 2027

    Native Bacterial and Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Chlamydia Antigens, Adenovirus Antigens, Borrelia Antigens, Chikungunya Virus Antigens, Clostridium Antigens, and Dengue Virus Antigens), Pathogen Type (Inactivated Pathogen and Purified Pathogen); Application (ELISA, Immunoassay, SDS-PAGE, Hemagglutination, and Agglutination Test), End User (Diagnostic Laboratories and Centers, and Academic and Research Institutes), and Geography

    Publication Month: Sep 2020 | Report Code: TIPRE00014757 | No. of Pages: 179 | Category: Biotechnology | Status: Published

    The native bacterial and viral antigens market is expected to reach US$ 28,801.15 thousand by 2027 from US$ 17,105.05 thousand in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027.

    Native antigens are extracted in their natural form from the respective sources. As they undergo usual modifications in vivo, upon isolation, they exhibit close resemblance withthe complex 3-dimensional structure they exhibit in the host. In the case of protein antigens, these modifications may include post-translational alterations such as cleavage of precursor proteins, formation of disulphide bonds, and addition of low molecular weight groups through processes such as glycosylation or phosphorylation. The global native bacterial and viral antigens market is driven by factors such as increasing use of native microbial antigens in diagnostics and therapeutics, and rising prevalence of infectious diseases. However, the limitations associated with native antigens such as high cost, low antigen production levels, and scale-up difficultieshinder the market growth.However, emerging markets are creating growth opportunities for the market players.

    Lucrative Regional Markets for Native Bacterial and Viral Antigens

    Lucrative Regional Markets for Native Bacterial and Viral Antigens

    Get more information on this report :



    Market Insights

    Increasing Use of Native Microbial Antigens in Diagnostics and Therapeutics

    Antigens are the biomolecules that are capable of triggering immune response in host body through the activation of lymphocytes. Bacterial antigens are used in the development of various types of antibodies in research laboratories for the improvement of immune systems. Moreover, bacterial antigens are also widely used in immunodiagnostic assays such as ELISA.

    Panning of native antigen libraries have led to development of potent neutralization antibodies against various bacterial and viral infections. The native antigens are extracted in their natural form from a corresponding source. There is high demand for a large number of native antigens, especially in in vitro diagnostics and vaccine research. According to various scientific studies, recombinant antigens exhibit solubility and aggregation issues. Further, the association of recombinant antigens with non-protein entities is also different and sometimes lacking in terms of performance as compared to native antigens.

    With the recent outbreak of COVID-19, companies are developing commercial SARS-CoV-2 antigens to support the vaccine formulation, and research and development to strengthen the disease diagnosis and therapy. In February 2020, the Native Antigen Company became the first company to commercially provide the novel coronavirus antigens, using the company’s proprietary VirtuE (HEK293) expression system. Thus, the rising use of native antigens, effectively supporting the diagnostics and therapeutics of various medical conditions, boosts the growth of the native bacterial antigen and antibody market.

    Product Type-Based Insights

    The native bacterial and viral antigens market,based on product type, is segmented into chlamydia antigens, adenovirus antigens, borrelia antigens, clostridium antigens, chikungunya virus antigens, and dengue virus antigens. The chlamydia antigens segment held the largest share of the market in 2019, and the market for the same is anticipated to grow at the highest CAGR during the forecast period. Growth of the market for this segment is attributed to easy availability of these antigens, with majority of the market players commercially offering these antigens in the native forms. Further, the use of chlamydiaantigens in research institutes and laboratories for the development of vaccines and in vitro diagnostics (IVD) tests is further expected to propel the growth of the market for this segment.

    Native Bacterial and Viral Antigens Market, by Technology– 2018 and 2027

    Native Bacterial and Viral Antigens Market, by Technology– 2018 and 2027

    Get more information on this report :



    Pathogen Type-Based Insights

    Based on pathogen type, the native bacterial and viral antigens market is segmented into inactivated pathogen and purified pathogen. The inactivated pathogen segment held a larger share of the market in 2019, and it is estimated to register a higher CAGR during the forecast period.

    Application-Based Insights

    Based on application, the native bacterial and viral antigens market is segmented into ELISA, immunoassay, SDS-PAGE, hemagglutination, and agglutination tests. The ELISA segment held the largest share of the market in 2019 and is estimated to register the highest CAGR during 2020–2027.

    End User-Based Insights

    Based on end user, the native bacterial and viral antigens market is segmented into diagnostic laboratories and centers and academic and research institutes. The diagnostic laboratories and centers segment held the largest share of the market in 2019, and it is estimated to register the highest CAGR from 2020 to 2027.


    Strategic Insights

    Product launches and approvalsare the commonly adopted strategies by companies to expand their global footprintsand product portfolios; these strategies help them meet the growing consumer demand. Collaboration is one of the major strategies adopted by the companies operating in the native bacterial and viral antigens market to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

    Native Bacterial and Viral Antigens Market – byProduct Type

    • Chlamydia Antigens 

    • Adenovirus Antigens
    • Borrelia Antigens
    • Chikungunya Virus Antigens
    • Clostridium Antigens
    • Dengue Virus Antigens


    Native Bacterial and Viral Antigens Market – by Pathogen Type

    • Inactivated Pathogen
    • Purified Pathogen


    Native Bacterial and Viral Antigens Market – by Application

    • ELISA
    • Immunoassay
    • SDS-PAGE
    • Hemagglutination
    • Agglutination Test


    Native Bacterial and Viral Antigens Market – by EndUser

    • Diagnostic Laboratories and Centers
    • Academic and Research Institutes


    Native Bacterial and Viral Antigens Market– by Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of Asia Pacific
    • Middle East and Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of Middle East and Africa
    • South and Central America

      • Brazil
      • Argentina
      • Rest of South America

    Company Profiles

    • BIO-RAD LABORATORIES INC.
    • Microbix Biosystems
    • SERION Immunologics
    • Aalto Bio Reagents Ltd
    • Enzo Life Sciences Inc.
    • Jena Bioscience GmbH
    • ROSS SOUTHERN LABORATORIES
    • The Native Antigen Company
    • Creative Diagnostics
    • TRINA BIOREACTIVES AG

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Native Bacterial and Viral Antigens Market – By Product Type

    1.3.2 Global Native Bacterial and Viral Antigens Market – By Pathogen Type

    1.3.3 Global Native Bacterial and Viral Antigens Market – By Application

    1.3.4 Global Native Bacterial and Viral Antigens Market – By End User

    1.3.5 Global Native Bacterial and Viral Antigens Market – By Geography

    2. Native Bacterial and Viral Antigens Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Global Native Bacterial and Viral Antigens Market – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe – PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East and Africa (MEA) – PEST Analysis

    4.2.5 South and Central America (SCAM) – PEST Analysis

    4.3 Expert Opinions

    5. Native Bacterial and Viral Antigens Market– Key Market Dynamics

    5.1.1 Increasing Use of Native Microbial Antigens in Diagnostics and Therapeutics

    5.1.2 Rising Prevalence of Infectious Diseases

    5.2 Market Restraints

    5.2.1 Limitations Associated with Native Antigens such as High Cost, Low Antigen Production Levels, Scale-up Difficulties

    5.3 Market Opportunities

    5.3.1 Developments in Emerging Economies

    5.4 Future Trend

    5.4.1 Growing Focus on Immunization Programs

    5.5 Impact Analysis

    6. Native Bacterial and Viral Antigens Market – Global Analysis

    6.1 Global Native Bacterial and Viral Antigens Market Revenue Forecast and Analysis

    6.2 Global Native Bacterial and Viral Antigens Market, By Geography - Forecast and Analysis

    6.3 Market Positioning of Key Players

    7. Native Bacterial and Viral Antigens Market Analysis – By Product Type

    7.1 Overview

    7.2 Native Bacterial and Viral Antigens Market Revenue Share, by Product Type (2019 and 2027)

    7.3 Chlamydia Antigens

    7.3.1 Overview

    7.3.2 Chlamydia Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    7.4 Adenovirus Antigens

    7.4.1 Overview

    7.4.2 Adenovirus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    7.5 Borrelia Antigens

    7.5.1 Overview

    7.5.2 Borrelia Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    7.6 Chikungunya Virus Antigens

    7.6.1 Overview

    7.6.2 Chikungunya Virus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    7.7 Clostridium Antigens

    7.7.1 Overview

    7.7.2 Clostridium Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    7.8 Dengue Virus Antigens

    7.8.1 Overview

    7.8.2 Dengue Virus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    8. Native Bacterial and Viral Antigens Market Analysis – By Pathogen Type

    8.1 Overview

    8.2 Native Bacterial and Viral Antigens Market Revenue Share, by Pathogen Type (2019 and 2027)

    8.3 Inactivated Pathogen

    8.3.1 Overview

    8.3.2 Inactivated Pathogen: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    8.4 Purified Pathogen

    8.4.1 Overview

    8.4.2 Purified Pathogen: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    9. Native Bacterial and Viral Antigens Market Analysis – By Application

    9.1 Overview

    9.2 Native Bacterial and Viral Antigens Market Revenue Share, by Application (2019 and 2027)

    9.3 ELISA

    9.3.1 Overview

    9.3.2 ELISA: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    9.4 Immunoassay

    9.4.1 Overview

    9.4.2 Immunoassay: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    9.5 SDS-PAGE

    9.5.1 Overview

    9.5.2 SDS-PAGE: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    9.6 Hemagglutination

    9.6.1 Overview

    9.6.2 Hemagglutination: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    9.7 Agglutination Test

    9.7.1 Overview

    9.7.2 Agglutination Test: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    10. Native Bacterial and Viral Antigens Market Analysis – By End User

    10.1 Overview

    10.2 Native Bacterial and Viral Antigens Market Revenue Share, by End User (2019 and 2027)

    10.3 Diagnostic Laboratories and Centers

    10.3.1 Overview

    10.3.2 Diagnostic Laboratories and Centers: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    10.4 Academic and Research Institutes

    10.4.1 Overview

    10.4.2 Academic and Research Institutes: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    11. Native Bacterial and Viral Antigens Market Analysis and Forecasts To 2027 Geographical Analysis

    11.1 North America: Native Bacterial and Viral Antigens Market

    11.1.1 Overview

    11.1.2 North America: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    11.1.3 North America: Native Bacterial and Viral Antigens Market, by Product Type, 2018–2027 (USD Thousand)

    11.1.4 North America: Native Bacterial and Viral Antigens Market, by Pathogen Type, 2018–2027 (USD Thousand)

    11.1.5 North America: Native Bacterial and Viral Antigens Market, By Application, 2018–2027 (USD Thousand)

    11.1.6 North America: Native Bacterial and Viral Antigens Market, By End User, 2018–2027 (USD Thousand)

    11.1.7 North America: Native Bacterial and Viral Antigens Market, by Country, 2019 & 2027 (%)

    11.1.8 US: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    11.1.8.1 US: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    11.1.8.2 US: Native Bacterial and Viral Antigens Market, by Product Type, 2018–2027 (USD Thousand)

    11.1.8.3 US: Native Bacterial and Viral Antigens Market, By Pathogen Type, 2018–2027 (USD Thousand)

    11.1.8.4 US: Native Bacterial and Viral Antigens Market, By Application, 2018–2027 (USD Thousand)

    11.1.8.5 US: Native Bacterial and Viral Antigens Market, By End User, 2018–2027 (USD Thousand)

    11.1.9 Canada: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    11.1.9.1 Canada: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    11.1.9.2 Canada: Native Bacterial and Viral Antigens Market, By Product Type, 2018–2027 (USD Thousand)

    11.1.9.3 Canada: Native Bacterial and Viral Antigens Market, By Pathogen Type, 2018–2027 (USD Thousand)

    11.1.9.4 Canada: Native Bacterial and Viral Antigens Market, By Application, 2018–2027 (USD Thousand)

    11.1.9.5 Canada: Native Bacterial and Viral Antigens Market, By End User, 2018–2027 (USD Thousand)

    11.1.10 Mexico: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    11.1.10.1 Mexico: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    11.1.10.2 Mexico: Native Bacterial and Viral Antigens Market, By Product Type, 2018–2027 (USD Thousand)

    11.1.10.3 Mexico: Native Bacterial and Viral Antigens Market, By Pathogen Type, 2018–2027 (USD Thousand)

    11.1.10.4 Mexico: Native Bacterial and Viral Antigens Market, By Application, 2018–2027 (USD Thousand)

    11.1.10.5 Mexico: Native Bacterial and Viral Antigens Market, By End User, 2018–2027 (USD Thousand)

    11.2 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027

    11.2.1 Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.2 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.2.3 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.2.4 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.2.5 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.2.6 Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)

    11.2.7 UK Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.7.1 UK Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.7.2 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.2.7.3 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.2.7.4 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.2.7.5 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.2.8 Germany Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.8.1 Germany Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.8.2 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.2.8.3 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.2.8.4 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.2.8.5 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.2.9 France Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.9.1 France Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.9.2 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.2.9.3 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.2.9.4 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.2.9.5 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.2.10 Italy Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.10.1 Italy Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.10.2 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.2.10.3 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.2.10.4 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.2.10.5 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.2.11 Spain Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.11.1 Spain Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.2.11.2 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.2.11.3 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.2.11.4 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.2.11.5 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.3 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027

    11.4 Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.1 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.4.2 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.4.3 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.4.4 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.4.5 Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)

    11.4.6 Japan Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.6.1 Japan Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.6.2 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.4.6.3 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.4.6.4 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.4.6.5 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.4.7 China Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.7.1 China Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.7.2 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.4.7.3 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.4.7.4 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.4.7.5 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.4.8 India Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.8.1 India Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.8.2 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.4.8.3 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.4.8.4 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.4.8.5 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.4.9 South Korea Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.9.1 South Korea Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.9.2 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.4.9.3 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.4.9.4 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.4.9.5 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.4.10 Australia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.10.1 Australia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.4.10.2 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.4.10.3 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.4.10.4 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.4.10.5 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.5 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027

    11.5.1 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.5.2 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.5.3 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.5.4 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.5.5 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.5.6 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)

    11.5.7 UAE Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.5.7.1 UAE Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.5.7.2 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.5.7.3 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.5.7.4 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.5.7.5 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.5.8 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.5.8.1 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.5.8.2 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.5.8.3 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.5.8.4 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.5.8.5 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.5.9 South Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.5.9.1 South Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.5.9.2 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.5.9.3 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.5.9.4 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.5.9.5 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.6 South And Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027

    11.6.1 South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.6.2 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.6.3 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.6.4 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.6.5 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.6.6 South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)

    11.6.7 Argentina Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.6.7.1 Argentina Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.6.7.2 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.6.7.3 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.6.7.4 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.6.7.5 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    11.6.8 Brazil Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.6.8.1 Brazil Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    11.6.8.2 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    11.6.8.3 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    11.6.8.4 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    11.6.8.5 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    12. Impact of COVID-19 Pandemic on Global Anti-Viral Therapies Market

    12.1 North America: Impact Assessment of COVID-19 Pandemic

    12.2 Europe: Impact Assessment of COVID-19 Pandemic

    12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    12.4 Rest of World: Impact Assessment of COVID-19 Pandemic

    13. Native Bacterial and Viral Antigens Market – Industry Landscape

    13.1 Overview

    13.2 Growth Strategies Done by the Companies in the Market, (%)

    13.3 Organic Developments

    13.3.1 Overview

    13.4 Inorganic Developments

    13.4.1 Overview

    14. Company Profiles

    14.1 BIO-RAD LABORATORIES INC.

    14.1.1 Key Facts

    14.1.2 Business Description

    14.1.3 Products and Services

    14.1.4 Financial Overview

    14.1.5 SWOT Analysis

    14.1.6 Key Developments

    14.2 Microbix Biosystems

    14.2.1 Key Facts

    14.2.2 Business Description

    14.2.3 Products and Services

    14.2.4 Financial Overview

    14.2.5 SWOT Analysis

    14.2.6 Key Developments

    14.3 SERION Immunologics

    14.3.1 Key Facts

    14.3.2 Business Description

    14.3.3 Products and Services

    14.3.4 Financial Overview

    14.3.5 SWOT Analysis

    14.3.6 Key Developments

    14.4 Aalto Bio Reagents Ltd

    14.4.1 Key Facts

    14.4.2 Business Description

    14.4.3 Products and Services

    14.4.4 Financial Overview

    14.4.5 SWOT Analysis

    14.4.6 Key Developments

    14.5 Enzo Life Sciences, Inc.,

    14.5.1 Key Facts

    14.5.2 Business Description

    14.5.3 Products and Services

    14.5.4 Financial Overview

    14.5.5 SWOT Analysis

    14.5.6 Key Developments

    14.6 Jena Bioscience GmbH

    14.6.1 Key Facts

    14.6.2 Business Description

    14.6.3 Products and Services

    14.6.4 Financial Overview

    14.6.5 SWOT Analysis

    14.6.6 Key Developments

    14.7 ROSS SOUTHERN LABORATORIES

    14.7.1 Key Facts

    14.7.2 Business Description

    14.7.3 Products and Services

    14.7.4 Financial Overview

    14.7.5 SWOT Analysis

    14.7.6 Key Developments

    14.8 The Native Antigen Company

    14.8.1 Key Facts

    14.8.2 Business Description

    14.8.3 Products and Services

    14.8.4 Financial Overview

    14.8.5 SWOT Analysis

    14.8.6 Key Developments

    14.9 Creative Diagnostics

    14.9.1 Key Facts

    14.9.2 Business Description

    14.9.3 Products and Services

    14.9.4 Financial Overview

    14.9.5 SWOT Analysis

    14.9.6 Key Developments

    14.10 TRINA BIOREACTIVES AG

    14.10.1 Key Facts

    14.10.2 Business Description

    14.10.3 Products and Services

    14.10.4 Financial Overview

    14.10.5 SWOT Analysis

    14.10.6 Key Developments

    15. Appendix

    15.1 About The Insight Partners

    15.2 Glossary of Terms

    LIST OF TABLES

    Table 1. North America Native Bacterial and Viral Antigens Market, by Product Type– Revenue and Forecast to 2027 (USD Thousand)

    Table 2. North America Native Bacterial and Viral Antigens Market, by Pathogen Type – Revenue and Forecast to 2027 (USD Thousand)

    Table 3. North America Native Bacterial and Viral Antigens Market, By Application – Revenue and Forecast to 2027 (USD Thousand)

    Table 4. North America Native Bacterial and Viral Antigens Market, By End User – Revenue and Forecast to 2027 (USD Thousand)

    Table 5. US Native Bacterial and Viral Antigens Market, by Product Type – Revenue and Forecast to 2027 (USD Thousand)

    Table 6. US Native Bacterial and Viral Antigens Market, By Pathogen Type – Revenue and Forecast to 2027 (USD Thousand)

    Table 7. US Native Bacterial and Viral Antigens Market, By Application – Revenue and Forecast to 2027 (USD Thousand)

    Table 8. US Native Bacterial and Viral Antigens Market, By End User – Revenue and Forecast to 2027 (USD Thousand)

    Table 9. Canada Native Bacterial and Viral Antigens Market, By Product Type – Revenue and Forecast to 2027 (USD Thousand)

    Table 10. Canada Native Bacterial and Viral Antigens Market, By Pathogen Type – Revenue and Forecast to 2027 (USD Thousand)

    Table 11. Canada Native Bacterial and Viral Antigens Market, By Application – Revenue and Forecast to 2027 (USD Thousand)

    Table 12. Canada Native Bacterial and Viral Antigens Market, By End User – Revenue and Forecast to 2027 (USD Thousand)

    Table 13. Mexico Native Bacterial and Viral Antigens Market, By Product Type – Revenue and Forecast to 2027 (USD Thousand)

    Table 14. Mexico Native Bacterial and Viral Antigens Market, By Pathogen Type – Revenue and Forecast to 2027 (USD Thousand)

    Table 15. Mexico Native Bacterial and Viral Antigens Market, By Application – Revenue and Forecast to 2027 (USD Thousand)

    Table 16. Mexico Native Bacterial and Viral Antigens Market, By End User – Revenue and Forecast to 2027 (USD Thousand)

    Table 17. Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 18. Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 19. Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 20. Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 21. UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 22. UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 23. UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 24. UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 25. Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 26. Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 27. Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 28. Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 29. France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 30. France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 31. France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 32. France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 33. Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 34. Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 35. Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 36. Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 37. Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 38. Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 39. Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 40. Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 41. Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 42. Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 43. Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 44. Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 45. Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 46. Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 47. Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 48. Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 49. China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 50. China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 51. China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 52. China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 53. India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 54. India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 55. India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 56. India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 57. South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 58. South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 59. South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 60. South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 61. Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 62. Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 63. Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 64. Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 65. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 66. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 67. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 68. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 69. UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 70. UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 71. UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 72. UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 73. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 74. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 75. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 76. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 77. South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 78. South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 79. South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 80. South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 81. South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 82. South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 83. South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 84. South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 85. Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 86. Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 87. Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 88. Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 89. Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)

    Table 90. Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)

    Table 91. Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

    Table 92. Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)

    Table 93. Organic Developments Done By Companies

    Table 94. Inorganic Developments Done by Companies

    Table 95. Glossary of Terms, Native Bacterial and Viral Antigens Market

    LIST OF FIGURES

    Figure 1. Native Bacterial and Viral Antigens Market Segmentation

    Figure 2. Native Bacterial and Viral Antigens Market Segmentation, By Region

    Figure 3. Native Bacterial and Viral Antigens Market Overview

    Figure 4. Chlamydia Antigens Segment Held Largest Share of Native Bacterial and Viral Antigens Market

    Figure 5. Europe to Show Significant Growth During Forecast Period

    Figure 6. Native Bacterial and Viral Antigens Market, by Geography (US$ Thousand)

    Figure 7. Global Native Bacterial and Viral Antigens Market – Leading Country Markets (US$ Thousand)

    Figure 8. Global Native Bacterial and Viral Antigens Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East and Africa (MEA) PEST Analysis

    Figure 13. South and Central America (SCAM) PEST Analysis

    Figure 14. Native Bacterial and Viral Antigens Market Impact Analysis of Driver and Restraints

    Figure 15. Global Native Bacterial and Viral Antigens Market – Revenue Forecast And Analysis – 2019- 2027

    Figure 16. Global Native Bacterial and Viral Antigens Market – By Geography Forecast and Analysis – 2019- 2027

    Figure 17. Market Positioning Of Key Players In Global Native Bacterial and Viral Antigens Market

    Figure 18. Native Bacterial and Viral Antigens Market Revenue Share, by Product Type (2019 and 2027)

    Figure 19. Chlamydia Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 20. Adenovirus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 21. Borrelia Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 22. Chikungunya Virus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 23. Clostridium Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 24. Dengue Virus Antigens: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 25. Native Bacterial and Viral Antigens Market Revenue Share, by Pathogen Type (2019 and 2027)

    Figure 26. Inactivated Pathogen: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 27. Purified Pathogen: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 28. Native Bacterial and Viral Antigens Market Revenue Share, by Application (2019 and 2027)

    Figure 29. ELISA: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 30. Immunoassay: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 31. SDS-PAGE: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 32. Hemagglutination: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 33. Agglutination Test: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 34. Native Bacterial and Viral Antigens Market Revenue Share, by End User (2019 and 2027)

    Figure 35. Diagnostic Laboratories and Centers: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 36. Academic and Research Institutes: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (US$ Thousand)

    Figure 37. North America: Native Bacterial and Viral Antigens Market, by Key Country – Revenue (2019) (USD Thousand)

    Figure 38. North America Native Bacterial and Viral Antigens Market Revenue and Forecast to 2027 (USD Thousand)

    Figure 39. North America: Native Bacterial and Viral Antigens Market, by Country, 2019 & 2027 (%)

    Figure 40. US: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    Figure 41. Canada: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    Figure 42. Mexico: Native Bacterial and Viral Antigens Market – Revenue and Forecast to 2027 (USD Thousand)

    Figure 43. Europe Native Bacterial and Viral Antigens Market Overview, by Country (2018)

    Figure 44. Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 45. Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)

    Figure 46. UK Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 47. Germany Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 48. France Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 49. Italy Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 50. Spain Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 51. Asia Pacific Native Bacterial and Viral Antigens Market Overview, by Country (2018)

    Figure 52. Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 53. Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)

    Figure 54. Japan Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 55. China Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 56. India Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 57. South Korea Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 58. Australia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 59. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue Overview, by Country, 2018 (US$ Thousand)

    Figure 60. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 61. Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)

    Figure 62. UAE Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 63. Saudi Arabia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 64. South Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 65. South and Central America Native Bacterial and Viral Antigens Market Revenue Overview, by Country, 2018 (US$ Thousand)

    Figure 66. South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 67. South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)

    Figure 68. Argentina Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 69. Brazil Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)

    Figure 70. Impact of COVID-19 Pandemic in North American Country Markets

    Figure 71. Impact of COVID-19 Pandemic in Europe Country Markets

    Figure 72. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

    Figure 73. Impact of COVID-19 Pandemic in Rest of World Country Markets

    Figure 74. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies - Native Bacterial and Viral Antigens Market

    1. BIO-RAD LABORATORIES INC.
    2. Microbix Biosystems
    3. SERION Immunologics
    4. Aalto Bio Reagents Ltd
    5. Enzo Life Sciences Inc.
    6. Jena Bioscience GmbH
    7. ROSS SOUTHERN LABORATORIES
    8. The Native Antigen Company
    9. Creative Diagnostics
    10. TRINA BIOREACTIVES AG
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the native bacterial and viral antigens market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global native bacterial and viral antigens market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPRE00014757
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market



    Frequently Asked Questions

    Native antigens are extracted in their natural form from an appropriate source. Because they have undergone the usual modifications that would occur in vivo, they bear a very close resemblance when isolated to the complex 3-dimensional structure they exhibit in the host. In the case of protein antigens, these modifications can include post-translational alterations such as cleavage of precursor proteins, formation of disulphide bonds, and addition of low molecular weight groups through processes such as glycosylation or phosphorylation.
    Factors such as increasing use of native microbial antigens in diagnostics and therapeutics, and rising prevalence of infectious diseases drive the growth of the market.Moreover, developments in emerging markets is expected to offer lucrative opportunities for the growth of the market.
    The native bacterial and viral antigensmarket majorly consists of the players such as BIO-RAD LABORATORIES, INC., Microbix Biosystems, SERION Immunologics, Aalto Bio Reagents Ltd., Enzo Life Sciences, Inc., Jena Bioscience GmbH, ROSS SOUTHERN LABORATORIES, The Native Antigen Company, Creative Diagnostics, and TRINA BIOREACTIVES AG amongst others.

    Pricing
    • $3000
    • $4550 $3640
    • $6550 $5240
    • $8550 $6840

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst